An update on osteoporosis

1. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. Journal of bone and mineral research. 1994; 9(8):1137-1141.10.1002/jbmr.5650090802Search in Google Scholar

2. Riggs BL, Melton Iii LJ. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 1995; 17(5):S505-S511.10.1016/8756-3282(95)00258-4Open DOISearch in Google Scholar

3. Rosen CJ, Compston JE, Lian JB. ASBMR primer on the metabolic bone diseases and disorders of mineral metabolism. 2009, John Wiley & Sons.Search in Google Scholar

4. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Stracke H. Risk of new vertebral fracture in the year following a fracture. Jama. 2001; 285(3):320-323.10.1001/jama.285.3.320Search in Google Scholar

5. Cooper C. The crippling consequences of fractures and their impact on quality of life. The American Journal of Medicine. 1997; 103(2):S12-S19.10.1016/S0002-9343(97)90022-XSearch in Google Scholar

6. Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D. Risk of mortality following clinical fractures. Osteoporosis International. 2000; 11(7):556-561.10.1007/s00198007007511069188Open DOISearch in Google Scholar

7. Sinescu RD, Niculae A, Peride I, Vasilescu F, Bratu OG, Mischianu DL, Checheriţă IA. Uterus neuroendocrine tumor–a severe prognostic factor in a female patient with alcoholic cirrhosis undergoing chronic hemodialysis. Rom J Morphol Embryol. 2015; 56(2):601-605.Search in Google Scholar

8. Bratu O, Mischianu D, Spanu D, Barla R, Hoara P, Constantinoiu S. Paraneoplastic Syndrome in Primitive Retroperitoneal Tumours. Chirurgia. 2013; 108:26-31.Search in Google Scholar

9. Niculae A, Peride I, Vinereanu V, Radulescu D, Bratu OG, Geavlete BF, Checherita IA. Nephrotic syndrome secondary to amyloidosis in a patient with monoclonal gammopathy with renal significance (MGRS). Rom J Morphol Embryol. 2017; 58(3):1065-1068.Search in Google Scholar

10. Niculae A, Peride I, Marinescu-Paninopol A, Vrabie CD, Ginghina O, Jecan CR, Bratu OG. Renal artery bilateral arteriosclerosis cause of resistant hypertension in hemodialysed patients. Rom J Morphol Embryol. 2016; 57(2):591-594.Search in Google Scholar

11. Checherita IA, Smarandache D, Radulesc D, Peride I, Bratu O, Ciocâlteu A, Lascar I. Calcific uremic arteriolopathy in hemodialyzed patients. Chirurgia. 2013; 108(5):736-740.Search in Google Scholar

12. Radulescu D, Stroescu A, Pricop C, Geavlete B, Negrei C, Bratu O, Vacaroiu IA. Vitamin K Influence on Cardiovascular Mortality in Chronic Hemodialysed Patients. Revista de Chimie. 2017; 68(1):52-54.10.37358/RC.17.1.5387Search in Google Scholar

13. Kling JM, Clarke BL, Sandhu NP. Osteoporosis prevention, screening, and treatment: a review. Journal of Women's Health. 2014; 23(7):563-572.10.1089/jwh.2013.4611408902124766381Search in Google Scholar

14. Warriner AH, Saag KG. Osteoporosis diagnosis and medical treatment. Orthopedic Clinics. 2013; 44(2):125-135.Search in Google Scholar

15. Nishizawa Y, Nakamura T, Ohta H, Kushida K, Gorai I, Shiraki M, Ichimura S. Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004). Journal of Bone and Mineral Metabolism. 2005; 23(2):97-104.Search in Google Scholar

16. Kanis JA, McCloskey EV, Johansson H, Oden A, Ström O, Borgström F. Development and use of FRAX® in osteoporosis. Osteoporosis International. 2010; 21(2):407-413.10.1007/s00198-010-1253-y20464374Open DOISearch in Google Scholar

17. Daroszewska A. Prevention and treatment of osteoporosis in women: an update. Obstetrics, Gynaecology & Reproductive Medicine. 2012; 22(6):162-169.10.1016/j.ogrm.2012.02.007Search in Google Scholar

18. Li K, Kaaks R, Linseisen J, Rohrmann S. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart. 2012; 98(12):920-925.10.1136/heartjnl-2011-30134522626900Open DOISearch in Google Scholar

19. Stevenson M, Jones ML, De Nigris E, Brewer N, Davis S, Oakley J. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. 2005.10.3310/hta922015929857Search in Google Scholar

20. Baim S, Miller PD. Perspective: assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw. Journal of Bone and Mineral Research. 2009; 24(4):561-574.10.1359/jbmr.09020319257812Open DOISearch in Google Scholar

21. Woo SB, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaws. Annals of Internal Medicine. 2006; 144(10):753-761.10.7326/0003-4819-144-10-200605160-0000916702591Search in Google Scholar

22. Park-Wyllie LY, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Laupacis A. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. Jama. 2011; 305(8):783-789.10.1001/jama.2011.19021343577Search in Google Scholar

23. Grimer RJ. Denosumab: a drug that you may be hearing a lot more about. Bone&Joint 360. 2013; 2(5):43-44.10.1302/2048-0105.25.360183Search in Google Scholar